Skip to main content

Table 2 Postoperative complications in patients treated with/without prophylactic HIPEC

From: Phase II trial of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer after curative surgery

 

Control group (n = 17)

Experimental group (n = 33)

P value

Alb (< 35 g/L/≥35 g/L)

15/2

25/8

0.069

Change of tumor markers, Decrease/stable/increase

1/9/7

6/23/4

0.020

Median hospitalization day after surgery

10 (7–22)

11 (8–24)

0.255

Median drainage tube removal time after surgery

8 (6–17)

9 (5–24)

0.159

Anastomotic leakage/Intestinal leakage, Yes/No

1/16

4/29

0.490

Wound infection/Poor wound healing, Yes/No

0/17

0/33

1.000

Ileus, Yes/No

0/17

0/33

1.000

Leukopenia, None/grade I/II

13/2/2

25/6/2

0.956

Neutropenia, None/grade I/II

13/2/2

28/3/2

0.453

Liver dysfunction, None/grade I/II

4/10/3

10/15/8

0.773

  1. Alb Albumin